Description

DESCRIPTION

This research peptide blend combines BPC‑157 (10mg) and TB‑500 (10mg), two extensively studied compounds known for their roles in tissue repair, angiogenesis, cellular protection, and musculoskeletal recovery. Research models often evaluate how these peptides may complement one another, supporting regenerative signaling pathways, improved microcirculatory dynamics, and accelerated structural restoration in controlled laboratory systems.

LYOPHILYZED PEPTIDES

These peptides are freeze‑dried to maintain purity, structural integrity, and long‑term stability. No fillers or excipients are used in this lyophilization process.

RESEARCH APPLICATIONS

1 — Musculoskeletal & Soft‑Tissue Regeneration

BPC‑157 and TB‑500 are each investigated for their potential roles in soft‑tissue recovery, including tendon, ligament, muscle, and epithelial models. Studies explore their combined influence on fibroblast migration, angiogenesis, and accelerated healing responses across musculoskeletal systems.

(References: Nature—https://www.nature.com/articles/s41598-020-78676-8, PubMed—https://pubmed.ncbi.nlm.nih.gov/33135667/ )

2 — Angiogenesis & Microcirculatory Support

Both peptides have been examined for modulating blood‑flow dynamics, supporting endothelial stability, and improving microvascular function in damaged or stressed tissues. Researchers frequently evaluate synergistic effects on angiogenic signaling and vascular repair models.

(References: ScienceDirect—https://www.sciencedirect.com/science/article/pii/S0944711319302200, PubMed—https://pubmed.ncbi.nlm.nih.gov/29385773/ )

3 — Anti‑Inflammatory & Cytoprotective Pathways

Laboratory studies suggest each peptide may influence cytokine regulation, oxidative‑stress protection, and cellular stability in disrupted micro‑environments. Their combined use is often applied in research exploring multi‑level inflammation‑modulating pathways.

(References: Frontiers—https://www.frontiersin.org/articles/10.3389/fphar.2021.808770/full, PubMed—https://pubmed.ncbi.nlm.nih.gov/21262318/ )

SPECIFICATIONS

Property | Details

Blend | BPC‑157 10mg + TB‑500 10mg (20mg total)

Amino Acid Sequences | BPC‑157: Gly‑Glu‑Pro‑Pro‑Pro‑Gly‑Lys‑Pro‑Ala‑Asp‑Asp‑Ala‑Gly‑Leu‑Val; TB‑500 active region: Ac‑Ser‑Asp‑Lys‑Pro‑Asp‑Met‑Ala‑Glu‑Ile‑Glu‑Lys‑Phe‑Glu‑Lys

Appearance | White to off‑white lyophilized powder

Purity | ≥ 99% (HPLC verified)

Form | Lyophilized powder

Solubility | Soluble in bacteriostatic water

Storage | Store dry at 2–8 °C; refrigerate after reconstitution

Usage | Laboratory research only

Research Data & References

– BPC‑157 angiogenesis data: https://pubmed.ncbi.nlm.nih.gov/33135667/

– TB‑500 cytoskeletal repair studies: https://www.sciencedirect.com/science/article/pii/S0944711319302200

Research Disclaimer

RESEARCH USE ONLY.
This product is not intended for therapeutic or diagnostic use. EOC Labs products are sold strictly for laboratory research and analytical purposes only. All information provided by EOC Labs, including descriptions, references, and technical data, is intended solely for educational and informational purposes. Statements have not been evaluated by the U.S. Food and Drug Administration (FDA). No claims are made for any medical or consumer application. By purchasing this product, the buyer certifies that it will be handled by qualified professionals in a properly equipped laboratory and used in compliance with all applicable local, state, and federal laws and regulations.